The DKK1 Knockout HeLa Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal population derived from HeLa cells, featuring targeted disruption of the DKK1 gene. This heterogeneous knockout model preserves the genetic diversity inherent to a mixed editing pool, avoiding artifacts associated with single-cell cloning. The loss of DKK1 abrogates the production of its secreted protein, a critical antagonist of the canonical Wnt signaling pathway, thereby enabling detailed interrogation of Wnt/??-catenin signal transduction in a human cervical epithelial carcinoma context.
HeLa cells are an immortalized line originating from an HPV18-positive cervical adenocarcinoma and serve as a cornerstone model for cancer research. Their robust growth, high transfectability, and extensive molecular characterization make them ideal for dissecting oncogenic pathways, particularly where viral proteins intersect with host signaling networks such as the Wnt pathway.
DKK1 encodes a secreted inhibitor of the canonical Wnt/??-catenin pathway, functioning by binding LRP5/6 co-receptors and KREMEN1/2 to induce receptor internalization, thereby blocking Wnt-Frizzled signal transduction. This prevents ??-catenin stabilization and transcriptional activation of targets including MYC, CCND1, AXIN2, and LEF1. DKK1 expression is regulated upstream by p53, TGF-??, BMP, and glucocorticoids, and is itself subject to feedback through ??-catenin/TCF. Within the pathway, it acts upstream of Dishevelled, GSK-3??, Axin, and APC, providing a crucial regulatory node.
In HeLa cells, DKK1 knockout unleashes Wnt signaling, promoting expression of oncogenes like MYC and CCND1, thereby enhancing proliferation and migration. This makes the model pertinent for investigating cervical cancer biology and for comparative studies with DKK1-related cancers such as multiple myeloma, breast, prostate, and colorectal carcinomas. Moreover, because DKK1 and Wnt activity influence bone metastasis, these cells are applicable in tumor-stroma interaction studies relevant to metastatic bone disease.
These polyclonal knockout cells are suited for Wnt reporter assays (TOPFlash/FOPFlash), western blotting of ??-catenin, RT-qPCR analysis of Wnt targets, and immunofluorescence monitoring of ??-catenin localization. Functional assays including proliferation and migration/invasion studies, as well as drug screening for Wnt modulators, are readily implemented. For further information, please contact Ascent Research.
